Venezuela's pharmaceutical sector grew over 10% in first half of 2026 | El Nacional (VE) | Economy News

Venezuela's pharmaceutical market experienced a significant increase of 10.77% in medication distribution during the first half of 2026, compared to the first six months of 2025. This growth indicates a positive trend in the availability and supply of medicines within the country.

In total, the sector distributed a cumulative volume of 209,934,255 healthcare units across the national commercialization network. The corporation Grupo Leti reported that medication sales reached 44,285,410 units in June alone, reinforcing the stability of the national supply chain.

Domestic laboratories contributed substantially to this growth, adding 6.28 million additional bottles and boxes during the semester. This local manufacturing effort represented 30.79% of the sector's overall expansion during this period. The emphasis on national production highlights efforts to bolster the internal pharmaceutical industry.

The segment of generic drugs emerged as the primary catalyst for consumption, registering an 11.04% rise. This translated to 97.97 million units distributed, making up nearly half of all medicines supplied nationwide. Additionally, presentations with fewer doses gained traction, with 42.47 million units delivered, constituting 43.35% of the generic segment and a fifth of all medical products dispatched in Venezuela during the analyzed timeframe.